TruLift lateral expandable spacer system and lateral plate system granted FDA approval

1722

Life Spine receives approval from FDALife Spine has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its TruLift lateral expandable spacer system and lateral plate system.

TruLift lateral and lateral plate system provide physicians with unique possibilities for their patient care, say Life Spine. TruLift lateral is offered in a range of sizes and footprints and can be expanded to the desired height (8mm to 16mm) to suit the patients’ individual pathology and anatomical conditions. The one-screw, two-screw, and four-screw lateral plates provide immediate stabilisation and fixation of the lumbar spine and may optionally attach to the TruLift lateral expandable spacer, add the company.

Rich Mueller, chief operating officer of Life Spine, said: “TruLift lateral and lateral plate system offer next-generation technology for lateral lumbar interbody fusions. The system features a robust titanium, expandable interbody that allows for plate fixation devices to attach easily and accurately. These plates are offered in multiple configurations and sizes. Separately or combined, these innovative systems further our commitment to micro invasive procedures.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here